Nycomed's profits up by 58% in first quarter, but OTC business suffers
29 May 2009
Sita Shah
Please Login to read the full article.
29 May 2009
Sita Shah
sita.shah@informa.com
Nycomed's profits rose by 58% to €88 million in the first quarter and it posted €840 million in net sales, up by 1% (+3.8% excluding currency effects) compared with the same period last year. However, the current global downturn affected the company's OTC business, with total OTC sales...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Silence at Takeda and Nycomed, but a desire to expand
- Takeda-Nycomed cuts 2,800 mainly EU jobs to eliminate extra ¥10 billion in overlaps
- Asia Beat: Takeda + Nycomed = panic buy or strategic masterstroke?
- A year in pharma and biotech R&D: Healthy numbers belie lack of novelty
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
